Digital Accessibility Statement

Laboratoire Aguettant is committed to making its websites, intranet, extranet, software packages and mobile applications accessible, in accordance with Article 47 of Law No. 2005-102 of 11 February 2005.

To this end, Laboratoire Aguettant is implementing the following strategy and actions:

This accessibility statement applies to the website: https://aguettant-corporate.com/fr/ 

Compliance status

The website https://aguettant-corporate.com/fr is partially compliant with the General Reference Framework for Accessibility Improvement (RGAA), version 4.1.2, due to the non-compliance items listed below.

Test results

The compliance audit carried out by the Novius agency shows that 64.40% of the RGAA version 4.1.2 criteria are met.

In detail:

  • Number of compliant criteria: 47
  • Number of non-compliant criteria: 26
  • Number of non-applicable criteria: 33

Our accessibility team is actively working to correct the criteria that remain non-compliant.

Inaccessible content

Non-compliance items

The content listed below is not accessible. Here is the list of non-compliant criteria:

1. Images

  • Criterion 1.2: Is each decorative image correctly ignored by assistive technologies?

→ Major

  • Criterion 1.3: For each image conveying information and having a text alternative, is this alternative relevant (except in special cases)?

→ Major

3. Colours

  • Criterion 3.1: On each web page, information must not be conveyed by colour alone. Is this rule respected?

→ Major

  • Criterion 3.2: On each web page, is the contrast between the text colour and its background colour sufficiently high (except in special cases)?

→ Major

4. Multimedia

  • Criterion 4.1: Does each pre-recorded time-based medium have, where necessary, a text transcript or audio description (except in special cases)?

→ Major

6. Links

  • Criterion 6.1: Is each link explicit (except in special cases)?

→ Major

  • Criterion 6.2: On each web page, does each link have a label?

→ Blocking

7. Scripts

  • Criterion 7.1: Is each script, where necessary, compatible with assistive technologies?

→ Major

  • Criterion 7.3: Is each script operable by keyboard and by any pointing device (except in special cases)?

→ Blocking

8. Mandatory elements

  • Criterion 8.6: For each web page that has a page title, is this title relevant?

→ Major

  • Criterion 8.7: On each web page, is each change of language indicated in the source code (except in special cases)?

→ Major

  • Criterion 8.9: On each web page, tags must not be used for presentation purposes only. Is this rule respected?

→ Minor

9. Structuring of information

  • Criterion 9.3: On each web page, is each list correctly structured?

→ Major

  • Criterion 9.4: On each web page, is each quotation correctly indicated?

→ Minor

10. Presentation of information

  • Criterion 10.6: On each web page, is each link whose nature is not obvious visible in relation to the surrounding text?

→ Blocking

  • Criterion 10.7: On each web page, for each element that receives focus, is the focus indicator visible?

→ Major

  • Criterion 10.11: For each web page, can the content be presented without loss of information or functionality, and without requiring either vertical scrolling for a window with a height of 256 px, or horizontal scrolling for a window with a width of 320 px (except in special cases)?

→ Blocking

11. Forms

  • Criterion 11.1: Does each form field have a label?

→ Blocking

  • Criterion 11.2: Is each label associated with a form field relevant (except in special cases)?

→ Major

  • Criterion 11.5: In each form, are fields of the same nature grouped together where necessary?

→ Major

  • Criterion 11.9: In each form, is the label of each button relevant (except in special cases)?

→ Major

  • Criterion 11.10: In each form, is input control used appropriately (except in special cases)?

→ Major

  • Criterion 11.11: In each form, is the input control accompanied, where necessary, by suggestions to help correct input errors?

→ Major

  • Criterion 11.13: Can the purpose of an input field be inferred to facilitate auto-filling of fields with user data?

→ Major

12. Navigation

  • Criterion 12.9: On each web page, navigation must not contain a keyboard trap. Is this rule respected?

→ Blocking

  • Criterion 12.11: On each web page, where necessary, can additional content appearing on hover, on focus, or on activation of an interface component be reached by keyboard?

→ Major

13. Consultation

  • Criterion 13.3: On each web page, does each downloadable office document have, where necessary, an accessible version (except in special cases)?

→ Major

Preparation of this accessibility statement

This statement was prepared on 01 April 2026.

Technologies used to build the website

  • HTML 5
  • CSS
  • JavaScript

Test environment

Content rendering checks were carried out using the combination provided in the RGAA reference base, with the following versions:

  • Google Chrome, Firefox + NVDA on Windows 11
  • Safari + VoiceOver on macOS 15

Tools used to assess accessibility

  • RGAA Assistant v4.1.2
  • WCAG Color Contrast Checker
  • HeadingsMap
  • Web Developer (code inspector)
  • ARC Toolkit
  • Wave (Web Accessibility Evaluation Tool)
  • PAC 2026 (PDF Accessibility Checker)
  • Accessibility Bookmarklets
  • Online tool app.asqatasun.org
  • Reference materials from the Temesis Auditor training course

Pages of the site covered by the compliance check

  1. Home page
    https://aguettant-corporate.com/fr/ 
  2. Contact
    https://aguettant-corporate.com/fr/contact/ 
  3. Legal notice
    https://aguettant-corporate.com/fr/mentions-legales/ 
  4. Privacy policy

https://aguettant-corporate.com/fr/politique-de-confidentialite/

  1. News

https://aguettant-corporate.com/fr/actualites/

  1. Join us

https://aguettant-corporate.com/fr/recrutement-offres-emploi/

  1. Aguettant, pharmaceutical laboratory

https://aguettant-corporate.com/fr/aguettant-laboratoire-pharmaceutique/

  1. The story of a commitment

https://aguettant-corporate.com/fr/aguettant-laboratoire-pharmaceutique/histoire-d-un-engagement/

  1. Our industrial sites

https://aguettant-corporate.com/fr/notre-presence-dans-le-monde/nos-sites-industriels/

  1. Our commercial subsidiaries

https://aguettant-corporate.com/fr/notre-presence-dans-le-monde/nos-filiales-commerciales/

  1. Expert in injectable medicines for hospitals

https://aguettant-corporate.com/fr/expert-du-medicament-injectable-a-l-hopital/

  1. Innovation & prefilled syringes

https://aguettant-corporate.com/fr/innovation-seringues-preremplies/

  1. Aguettant Academy

https://aguettant-corporate.com/aguettant-academy/

Feedback and contact

If you are unable to access content or a service, you may contact the person responsible for https://aguettant-corporate.com/fr/  to be directed to an accessible alternative or to obtain the content in another format.

Means of appeal

If you notice an accessibility failure preventing you from accessing content or a feature of the site, and after reporting it to us you do not receive a satisfactory response, you are entitled to send your complaint or a request to the Défenseur des droits (the French Rights Defender).

Several options are available to you:

Défenseur des droits

Libre réponse 71120

75342 Paris CEDEX 07


 chevron-uparrow-right